Results 151 to 160 of about 59,354 (258)

Patient‐Derived IgG Epitope Mapping of Bet v 1 Reveals Hypoallergenic Peptide Candidates for Safe and Next‐Generation Allergen Immunotherapy

Clinical &Experimental Allergy, EarlyView.
Mapping IgG epitopes of the major birch allergen Bet v 1 identified patient‐derived, hypoallergenic peptides that did not trigger degranulation. These findings support a novel, safer approach for peptide‐based allergen immunotherapy that leverages naturally induced IgG specificities from allergic individuals. ABSTRACT Background Allergen immunotherapy (
Lara Šošić, Marta Paolucci, Alessandro Streuli, David A. Melillo, Tianchi Jiang, Raffaela Campana, Claudia C. V. Lang, Thomas M. Kündig, Christian Steuer, Klaus Eyer, Pål Johansen   +10 more
wiley   +1 more source

Th9 and IL9 in Chronic Superior Airway Inflammation: A Narrative Review. [PDF]

Biomedicines
Dumitru M, Berghi O, Musat G, Serboiu C, Oancea A, Berghi AG, Zamfir-Chiru-Anton A, Vrinceanu D.   +7 more
europepmc   +1 more source

Translation and Validation of the Rhinitis Control Assessment Test (RCAT) for Allergic Rhinitis in Urdu Language. [PDF]

Int Arch Otorhinolaryngol
Adeel M, Nawaz A, Larik HA, Pyarali M, Ali A, Tariq R, Arbani N, Iftikhar H.   +7 more
europepmc   +1 more source

Comparison of the efficacy of different doses of omalizumab (150 mg vs 300 mg) in patients with seasonal allergic rhinitis and low total IgE: A randomized, double-blind, controlled study. [PDF]

World Allergy Organ J
Li L, Xu Y, Bian S, Pan Z, Guan K.
europepmc   +1 more source

Prevalence and Sociodemographic Variation of Allergic Diseases in Australia: Findings From the Australian National Health Survey

Clinical &Experimental Allergy, EarlyView.
Using data from 17,093 participants in the 2022 Australian National Health Survey, this study is the first to report nationwide prevalence estimates for allergic rhinitis (23.9%), food allergy (7.0%), drug allergy (5.2%), eczema (1.6%) and diagnosed asthma (10.8%) across Australia.
Yichao Wang, Jennifer J. Koplin, Janet M. Davies, Constance H. Katelaris, Debra J. Palmer, Jason A. Trubiano, Joy Lee, Michaela Lucas, Michael O′Sullivan, Sandra Vale, Sheryl van Nunen, Troy Wanandy, Dianne E. Campbell, Kirsten P. Perrett, Rachel L. Peters   +14 more
wiley   +1 more source

Leukotriene-modifying agent chemoprophylaxis for severe influenza illness: a multi-approach study. [PDF]

Am J Epidemiol
Snyder BM, Riddell CA, Gebretsadik T, Ding T, Lee RL, Dupont WD, Ortiz JR, Pav V, Braciale TJ, Wu P, Hartert TV.   +10 more
europepmc   +1 more source

Rebound Pruritus and Urticaria After Discontinuation of Chronic Antihistamine Use—A Scoping Review

Clinical &Experimental Allergy, EarlyView.
Rebound pruritus and urticaria have been reported after discontinuation of chronic cetirizine or levocetirizine use only. Symptoms typically occur within 0.5–5 days after stopping therapy and appear more frequently reported in female patients. Re‐initiation of antihistamines is the most commonly effective management strategy, highlighting the need for ...
Jun Jie Benjamin Seng, Prawira Oka, Ngiap Chuan Tan   +2 more
wiley   +1 more source

Research on pollen allergy in Fuzhou, China: from the online public concern surveys to pollen monitoring. [PDF]

Front Public Health
Yue X, Guo M, Chen T, Li C, Wang Y, Liu Y, Zheng H, He Z.   +7 more
europepmc   +1 more source

Stellate ganglion block causing reproducible improvement of allergic rhinitis and asthma: a case report. [PDF]

Pain Rep
Ahmad A, Perez-Bravo E.
europepmc   +1 more source

Rheumatoid arthritis and airway hyperresponsiveness: A GWAS-based mendelian randomization study. [PDF]

Medicine (Baltimore)
Shu H, Wang Y, Shen R, Qian C, Anniwaer A, Ling X, Zhu X, Shen H, Zhang Q.   +8 more
europepmc   +1 more source